Opinion|Videos|September 30, 2024
Recent Fecal Microbiota Transplant Approvals for C. difficile Infections
Carl V. Crawford, MD, provides a comprehensive overview of the two FDA-approved FMT therapies for patients with recurrent C. difficile infections.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- We currently have 2 FDA-approved FMT therapies for recurrent CDI. Can you provide an overview of these two therapies? What bacterial species do they contain?
Advertisement
Related to this article
A new study in infants challenges the long-standing belief about the pathogen’s effects in the youngest pediatric population. Senior author Joseph Zackular, PhD, provides insights around his work including how it reshapes gut development and offers potential intervention strategies to shield neonates.